Page 1

DocMorris Frauenfeld , 19 August 2026 Press release Ad hoc announcement pursuant to Art . 53 LR DocMorris with strong growth momentum in Rx and Digital Services in the first half of the year and guidance increase Continued revenue momentum in the first half of the year , up 12.5 % Growth of 38.3 % in Rx ( Q2 : 45.8 % ) and 71.4 % in Digital Services ( Q2 : 80.0 % ) Adjusted EBITDA improved by CHF 17.9 million to minus CHF 10.9 million All elements of the guidance for 2026 have been increased following the first - half results and the ongoing positive business performance CEO Walter Hess says : “ Our revenue momentum and operational efficiency clearly improved across all ar- eas in the first half of 2026. Particularly encouraging are the Rx growth , with strong new customer acquisi- tion , and the growth in Digital Services in the first half of the year . This positive development allows us to raise the range of our full - year revenue and adjusted EBITDA guidance . " CFO Daniel Wüest adds : “ We were able to increase adjusted EBITDA by CHF 17.9 million year - on - year in the first half of 2026 , and by CHF 1.7 million in the second quarter compared to the first quarter . Key driv- ers included a further improvement in marketing efficiency in the Rx business and increased profit contribu- tions from Digital Services . The results achieved in the first half of the year , together with the first few weeks of the third quarter , give us further confidence that we will reach EBITDA breakeven in the second half of 2026. " Structural improvement in earnings amid continued strong revenue momentum External revenue¹ rose by 12.5 per cent² year - on - year to CHF 627.8 million in the first half of 2026 , whilst revenue increased by 13.4 per cent to CHF 599.2 million . All segments and business areas contributed to this encouraging growth ( see press release of 15 July 2026 ) . Adjusted EBITDA improved by CHF 17.9 million year - on - year to minus CHF 10.9 million in the first half of 2026. From the first to the second quarter of 2026 , adjusted EBITDA improved further sequentially from minus CHF 6.3 million to minus CHF 4.6 million . The EBITDA of minus CHF 20.0 million includes one - off extraordinary costs of CHF 7.6 million , relating , amongst other things , to the implementation of the AI - First strategy ( see press release of 25 June 2026 ) and the closure of the Ludwigshafen site , which was announced and executed in the first quarter of 2026. These expenses will be largely offset in the second half of the year due to the resulting cost savings . ¹ External revenue consists of the revenue of DocMorris plus online revenues of apotal , less revenue related to sup- plies to apotal . All percentages are in local currency . DocMorris AG Walzmühlestrasse 49 8500 Frauenfeld Switzerland corporate.docmorris.com